key: cord-0069282-ygl9n9sf
authors: Qiu, Shizheng; Li, Meijie; Jin, Shunshan; Lu, Haoyu; Hu, Yang
title: Rheumatoid Arthritis and Cardio-Cerebrovascular Disease: A Mendelian Randomization Study
date: 2021-10-21
journal: Front Genet
DOI: 10.3389/fgene.2021.745224
sha: 34c5888e5a244e66a9315dad0fa79e2e2091e368
doc_id: 69282
cord_uid: ygl9n9sf

Significant genetic association exists between rheumatoid arthritis (RA) and cardiovascular disease. The associated mechanisms include common inflammatory mediators, changes in lipoprotein composition and function, immune responses, etc. However, the causality of RA and vascular/heart problems remains unknown. Herein, we performed Mendelian randomization (MR) analysis using a large-scale RA genome-wide association study (GWAS) dataset (462,933 cases and 457,732 controls) and six cardio-cerebrovascular disease GWAS datasets, including age angina (461,880 cases and 447,052 controls), hypertension (461,880 cases and 337,653 controls), age heart attack (10,693 cases and 451,187 controls), abnormalities of heartbeat (461,880 cases and 361,194 controls), stroke (7,055 cases and 454,825 controls), and coronary heart disease (361,194 cases and 351,037 controls) from United Kingdom biobank. We further carried out heterogeneity and sensitivity analyses. We confirmed the causality of RA with age angina (OR = 1.17, 95% CI: 1.04–1.33, p = 1.07E−02), hypertension (OR = 1.45, 95% CI: 1.20–1.75, p = 9.64E−05), age heart attack (OR = 1.15, 95% CI: 1.05–1.26, p = 3.56E−03), abnormalities of heartbeat (OR = 1.07, 95% CI: 1.01–1.12, p = 1.49E−02), stroke (OR = 1.06, 95% CI: 1.01–1.12, p = 2.79E−02), and coronary heart disease (OR = 1.19, 95% CI: 1.01–1.39, p = 3.33E−02), contributing to the understanding of the overlapping genetic mechanisms and therapeutic approaches between RA and cardiovascular disease.

Cardiovascular disease remains the leading cause of human death, with an estimated 17.3 million people worldwide dying of cardiovascular disease each year, which is expected to increase to 23.6 million by 2030 (Laslett et al., 2012; Smith et al., 2012; Leong et al., 2017) . Epidemiological studies have shown that the occurrence of cardiovascular disease is caused by various factors, with obesity, diabetes, smoking, hyperlipidemia, atherosclerosis, hypertension, and blood viscosity being its potential risk factor (Leong et al., 2017; Xu et al., 2019) . Importantly, traditional cardiovascular disease risk factors account for a large proportion of rheumatoid arthritis (RA) . RA patients were 48% more likely to have cardiovascular disease than normal people and a 50% higher incidence of cardiovascular disease-related mortality (Avina-Zubieta et al., 2008 Sokka et al., 2008; England et al., 2018) . However, most of the previous studies have examined the association between RA and atherosclerosis and congestive heart failure, ignoring other phenotypes of heart disease and vascular problems (England et al., 2018) . Moreover, the exact causality is still unknown.

Mendelian randomization (MR) could estimate causality without bias, which has been used in previous studies to explore the association between phenotypes (Jansen et al., 2014; Smith et al., 2017; Hemani et al., 2018; Cheng et al., 2019b Cheng et al., , 2021 Zhuang et al., 2019; Qiu et al., 2021) . Causality between multiple metabolic characteristics, nutrient elements, and common diseases with cardiovascular disease have been demonstrated (Ference et al., 2017; Larsson et al., 2017 Larsson et al., , 2020 Yeung et al., 2018; Rosoff et al., 2020; Arvanitis et al., 2021) . However, strong evidence linking RA to cardiovascular disease is still lacking. Herein, we mainly selected inversevariance weighted (IVW), weighted median, and MR-Egger methods for MR analysis. We provided strong evidence that RA contributed to six vascular-/heart problem-related phenotypes, which could be of great significance for clinical disease prevention and treatment.

We obtained large-scale genome-wide association study (GWAS) summary datasets from the United Kingdom Biobank on RA and six cardiovascular disease phenotypes, and all of the participants were of European ancestry. From 2006 to 2010, the United Kingdom Biobank Assessment Center recruited 386,005 participants from the United Kingdom to participate in selfreporting of non-cancer illness (Li et al., 2015; Sun et al., 2019) . RA GWAS (462,933 cases and 457,732 controls) was derived from the non-cancer illness study. At the same time, the United Kingdom Biobank Assessment Center carried out the study of vascular/heart problems diagnosed by doctors, covering 501,555 participants. These heart or vascular problems included age angina (461,880 cases and 447,052 controls), age high blood pressure (461,880 cases and 337,653 controls), age stroke (7,055 cases and 454,825 controls), and age heart attack (10,693 cases and 451,187 controls). In addition, we supplemented two other United Kingdom Biobank studies on coronary heart disease (CHD) (361,194 cases and 351,037 controls) and abnormalities of heartbeat (461,880 cases and 361,194 controls).

In order to enhance the statistical power of genetic variants, we deleted single-nucleotide polymorphisms (SNPs) with a minor allele frequency (MAF) < 1%. Moreover, we removed variants with physical distance less than 10,000 kb and R 2 < 0.001 to avoid linkage disequilibrium (LD). For preprocessed exposure (RA) data, we selected genetic variants that passed genome-wide association threshold (p < 5E−08) as instrumental variables (IVs) to satisfy IV assumption 1 of MR analysis: variants should be strongly associated with exposure (RA) (Hemani et al., 2018) .

In the absence of individual-level data, we used MR, a powerful statistical method, to infer the causality between two phenotypes. MR analysis eliminates the need to consider confounders and reverse causality. Two-sample MR requires that the samples of exposure and outcome be independent, which greatly expands the application range of MR (Hemani et al., 2018) . Details of MR analysis have been described in previous reports (Davey Smith and Hemani, 2014; Bowden et al., 2015 Bowden et al., , 2016 Yavorska and Burgess, 2017; Cheng et al., 2018 Cheng et al., , 2019b Hemani et al., 2018; Hu et al., 2020 Hu et al., , 2021 Qiu et al., 2021) . Herein, we first aligned alleles on the forward strand and harmonized SNP effects of exposure and outcome (Ong et al., 2021) . If the variant in IVs was lacking in outcome, we allowed the proxy SNP with a strong LD to replace it (Hemani et al., 2018) . Subsequently, we performed the inverse-variance weighted (IVW) estimator to estimate the association between RA and vascular/heart disease (Burgess and Thompson, 2017) . In the case of certain invalid instruments or directional pleiotropy bias, the weighted median and MR-Egger estimators could help to make further judgment Burgess and Thompson, 2017; Hartwig et al., 2017; Cheng, 2019; Cheng et al., 2019a) . Finally, we carried out reverse MR analysis to evaluate the evidence for reverse causal association.

We performed a series of sensitivity tests to ensure that our results were robust, including heterogeneity tests to assess heterogeneity between IVs, leave-one-out analysis (Wei et al., 2019 (Wei et al., , 2021 Govindaraj et al., 2020; Hasan et al., 2021) to assess whether a single SNP over-drove outcome, and funnel plots and MR-Egger to assess potential horizontal pleiotropy Hartwig et al., 2017; Rosoff et al., 2020) . The statistical tests for MR analysis were undertaken using the R package of meta and TwoSampleMR (Hemani et al., 2018) . The statistically significant association is defined as p < 0.05.

Eight genetic variants were used as IVs to evaluate the association between RA and cardiovascular disease ( Table 1) . Two SNPs needed to be proxied, but we lacked evidence for the presence of wrong effect alleles, strand issues, palindromic SNPs, and incompatible alleles. Due to the heterogeneity in some studies, we preferred to use the random-effects model ( Table 2) . By performing IVW analysis, we confirmed the causality of RA with age angina (OR = 1.17, 95% CI: 1.04-1.33, p = 1.07E−02), hypertension (OR = 1.45, 95% CI: 1.20-1.75, p = 9.64E-05), age heart attack (OR = 1.15, 95% CI: 1.05-1.26, p = 3.56E-03), abnormalities of heartbeat (OR = 1.07, 95% CI: 1.01-1.12, p = 1.49E−02), stroke (OR = 1.06, 95% CI: 1.01-1.12, p = 2.79E−02), and CHD (OR = 1.19, 95% CI: 1.01-1.39, p = 3.33E−02) (Figure 1) . Detailed MR results are shown in Beta is the estimated effect size for the effect allele; Beta > 0 and Beta < 0 means that this effect allele could increase and reduce RA risk, respectively. EAF, effect allele frequency. Leave-one-out analysis: p < 0.05 means that no single single-nucleotide polymorphism (SNP) over-drives the overall results. 

Unlike IVW, MR-Egger allows horizontal pleiotropy between IVs and exposure and outcome, and the weighted median allows a more powerful variant to have a greater impact on the overall result Hartwig et al., 2017; Qiu et al., 2021) . Other MR calculation methods are a powerful supplement to IVW, especially when the IV assumptions of MR framework is not satisfied perfectly. In all methods, our results were robust, with small intercepts and high p-values in MR-Egger, which meant that horizontal pleiotropy made almost no effect on the results (Figure 2 and Table 2 ). According to funnel plots, rs7731626 and rs460568 in angina, and rs6679677 and rs9265076 in CHD, there existed a certain horizontal pleiotropy; however, little influence affected the overall results (Figure 3) . Moreover, no single SNP over-drove the overall results.

In this study, we carried out MR analysis to demonstrate that RA was positively associated with six heart and vascular diseases. Observational studies evaluated that the patients with RA had a significantly increased risk of cardiovascular disease Crowson et al., 2018) . Crowson et al. (2018) followed up 5,638 RA patients for 5.8 years and found that about 30% of them eventually developed cardiovascular disease. RA might increase the risk of the six heart and vascular diseases we mentioned at the same time ( Kitas and Gabriel, 2011; Dougados et al., 2014; Hadwen et al., 2021) . Thus, we subdivided the phenotypes of cardiac and vascular diseases to provide different risk values, which might be a significant help for the clinical cotreatment of RA and cardiovascular disease.

Our study may have many advantages over previous observational studies. First, we used seven large-scale GWAS datasets. RA GWAS alone involved more than 900,000 participants. The seven studies were all from European descent, avoiding potential population stratification. Second, MR greatly avoids the influence of confounding factors and reverse causality because the alleles of the SNP site are randomly assigned much earlier than the occurrence of any potential confounding factors. Third, we applied a variety of MR methods to jointly verify the robustness of the results. When some instruments were unavailable or horizontal pleiotropy, an unbiased causal estimate could still be given.

However, certain limitations existed in our study. First, there may be overlap of some samples in RA GWAS and cardiovascular disease GWAS, which leads to weak instruments bias (Pierce and Burgess, 2013) . In addition, some of the genetic variants have a certain degree of heterogeneity or horizontal pleiotropy, such as rs7731626 and rs9265076, in the analysis of RA and angina. For population stratification from gender, age, and ancestry, inappropriate proxy SNP may be the potential reasons for them.

In conclusion, we explored the causality between RA and six cardio-cerebrovascular diseases for the first time, and all the results showed the risk effect of RA. Eight variants as IVs may be the link between RA and cardiovascular disease. We expect to find out the genetic association between chronic diseases more deeply in the future.

The original contributions presented in the study are included in the article/ Supplementary Material, further inquiries can be directed to the corresponding author/s.

SQ and LH designed the study, analyzed the data, and wrote the manuscript. ML and SJ revised the manuscript. YH supervised the research and revised the manuscript. All authors contributed to the article and approved the submitted version. 

Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis

Linear and nonlinear mendelian randomization analyses of the association between diastolic blood pressure and cardiovascular events the J-curve revisited

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

A framework for the investigation of pleiotropy in twosample summary data mendelian randomization

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator

Interpreting findings from mendelian randomization using the MR-Egger method

Computational and biological methods for gene therapy

Computational methods for identifying similar diseases

COVID-19 induces lower levels of IL-8, IL-10, and MCP-1 than other acute CRS-inducing diseases

Exposing the causal effect of body mass index on the risk of type 2 diabetes mellitus: a mendelian randomization study

Exposing the causal effect of C-reactive protein on the risk of type 2 Diabetes mellitus: a mendelian randomization study

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Extremely-randomized-tree-based Prediction of N(6)-methyladenosine Sites in Saccharomyces cerevisiae

Risk factors for hypertension in rheumatoid arthritis patients-a systematic review

Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption

Critical evaluation of web-based DNA N6-methyladenine site prediction tools

The MR-Base platform supports systematic causal inference across the human phenome

rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues

rs34331204 regulates TSPAN13 expression and contributes to Alzheimer's disease with sex differences

Mendelian randomization studies in coronary artery disease

Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives

Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a mendelian randomization study

Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction

The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues a report from the American College of Cardiology

Reducing the global burden of cardiovascular disease, part 2 Prevention and treatment of cardiovascular disease

An overview of SNP interactions in genome-wide association studies

A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using mendelian randomization

Efficient design for mendelian randomization studies: subsample and 2-sample instrumental variable estimators

Exploring the causality between hypothyroidism and non-alcoholic fatty liver: a mendelian randomization study

Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: a multivariable mendelian randomization study

When will mendelian randomization become relevant for clinical practice and public health?

Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)

Mortality in rheumatoid arthritis: 2008 update

HS-MMGKG: a fast multi-objective harmony search algorithm for two-locus model detection in GWAS

Computational prediction and interpretation of cell-specific replication origin sites from multiple eukaryotes by exploiting stacking framework

Iterative feature representations improve N4-methylcytosine site prediction

Bioinformatics study on serum triglyceride levels for analysis of a potential risk factor affecting blood pressure variability

MendelianRandomization: an R package for performing mendelian randomization analyses using summarized data

The impact of glycated hemoglobin (HbA(1c)) on Cardiovascular disease risk: a mendelian randomization study using UK Biobank

A Mendelian randomization study on infant length and type 2 diabetes mellitus risk

We would like to thank the United Kingdom Biobank for the GWAS summary statistics (http://www.nealelab.is/uk-biobank/).

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene. 2021.745224/full#supplementary-material

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.